▲ Peaking
Business
Biotech Goes Sky-High After LSD Drug Treats Depression
Definium Therapeutics shares climb following the release of phase 3 clinical trial results for an LSD-based depression treatment.
1 trends tracked about this subject — the full history, oldest to newest below.
Definium Therapeutics shares climb following the release of phase 3 clinical trial results for an LSD-based depression treatment.